Long-term therapy of duodenal ulcer disease

B. Annibale, E. Rauws, V. Savarino

Research output: Contribution to journalArticlepeer-review


A questionnaire was sent to 88 centres in 23 countries (Table I) in an attempt to record their day-to-day behaviour and to reach consensus regarding the long-term treatment of duodenal ulcer disease. The choice of centres was dictated by those authors who had published clinical studies on this topic; 62% (n = 54) completed and returned the questionnaire. The survey thus represents the current practice of many major centres in the long-term treatment for duodenal ulcer. Some answers need to be interpreted cautiously because certain drugs (colloidal bismuth subcitrate, sucralfate, omeprazole) are not on the market in all countries or are not registered for the long-term treatment of duodenal ulcer.

Original languageEnglish
Pages (from-to)109-112
Number of pages4
JournalGastroenterology International
Issue number2
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Long-term therapy of duodenal ulcer disease'. Together they form a unique fingerprint.

Cite this